<script src="https://cdn.tailwindcss.com"></script>
<script>
  tailwind.config = {
    content: [
      './templates/**/*.html.twig',
      './js/**/*.js',
    ],
    theme: {
      extend: {
        colors: {
          primary: {
            DEFAULT: '#a05ea6',
            light: '#a05ea6',
            10: 'rgba(160, 94, 166, 0.1)',
            gradient: {
              start: '#A05EA7',
              end: '#765FA4'
            }
          },
          secondary: '#739549',
          text: {
            DEFAULT: '#191919',
            muted: '#777776'
          },
          border: {
            muted: 'rgba(115, 117, 120, 0.3)'
          },
          teal: '#0080a3',
          dark: '#231f20'
        },
        fontFamily: {
          sans: ['Arial', 'sans-serif'],
        },
        container: {
          center: true,
          padding: '1rem',
          screens: {
            sm: '640px',
            md: '768px',
            lg: '1024px',
            xl: '1280px',
            '2xl': '1440px',
          },
        },
        spacing: {
          '18': '4.5rem',
        },
        backgroundImage: {
          'fade-white': 'linear-gradient(to bottom, #fff 80%, rgba(255,255,255,0) 100%)',
          'primary-gradient': 'linear-gradient(to right, #A05EA7, #765FA4)',
          'teal-primary-gradient': 'linear-gradient(to right, #0081a3 0%, #a05fa6 322.36%)',
          'teal-primary-gradient-2': 'linear-gradient(to right, #0081a3 -110.9%, #a05fa6 211.89%)',
          'teal-primary-gradient-3': 'linear-gradient(to right, #0081a3 -221.37%, #a05fa6 100%)'
        }
      },
    },
    plugins: [],
  }
</script>



<div class="w-full max-w-[1440px] overflow-hidden m-auto">
  <div class="flex flex-col gap-8 md:gap-16 pb-8 md:pb-16 bg-white">
    <div class="flex flex-col gap-8">

      <div class="w-full overflow-hidden bg-white">
        <div class="bg-[url('frame-626252.png')]">
          <div class="opacity-90 gap-8 px-3 md:px-[150px]">
            <p class="w-full max-w-[1140px] text-center text-text">
              <span class="text-[32px] md:text-[40px] font-semibold text-center">CHOLBAM may help your patients with
                SLOS</span>
              <span class="text-[40px] text-center">1-3*:</span>
            </p>
            <div class="gap-6 md:gap-10">
              <!-- Mobile layout -->
              <div class="flex flex-col md:hidden w-full">
                <div class="flex flex-col items-center w-full gap-2 pt-2 pb-6 rounded-2xl">
                  <div class="px-24 gap-2.5"></div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="flex flex-col items-center gap-4">
                      <p class="w-full max-w-[351px] text-[26px] text-center text-teal">
                        <span class="font-semibold">Increase plasma cholesterol</span><span>â€&nbsp;</span>
                      </p>
                    </div>
                  </div>
                </div>
                <div class="flex flex-col items-center w-full gap-2 pt-2 pb-6 rounded-2xl">
                  <div class="px-24 gap-2.5"></div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="flex flex-col items-center gap-4">
                      <p class="w-full max-w-[351px] text-[26px] font-semibold text-center text-teal">
                        Lower key liver enzymes
                      </p>
                      <div class="flex flex-col items-center gap-4">
                        <p class="w-full max-w-[351px] text-lg text-left text-text">
                          <span>Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) values </span>
                          <span class="font-bold">reduced</span>
                          <span> to less than 50 U/L, or baseline levels </span>
                          <span class="font-bold">reduced</span>
                          <span> by 80%. </span><br><br>
                          <span>Total bilirubin values </span>
                          <span class="font-bold">reduced</span>
                          <span> to less than or equal to 1 mg/dL.</span>
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
                <div class="flex flex-col items-center w-full gap-2 pt-2 rounded-2xl">
                  <div class="px-24 gap-2.5"></div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="flex flex-col items-center gap-4">
                      <p class="w-full max-w-[351px] text-[26px] font-semibold text-center text-teal">
                        Improve certain growth parameters
                      </p>
                      <div class="flex flex-col items-center gap-4">
                        <p class="w-full max-w-[351px] text-lg text-left text-text">
                          <span>In a pivotal study, responders saw a </span>
                          <span class="font-bold">9% increase in body weight or maintained weight above the 50th
                            percentile</span>
                          <span>.1*</span><br><br>
                          <span>In a 2-month pilot study, 9 of 12 patients showed an </span>
                          <span class="font-bold">increasing trend in weight gain</span>
                          <span> from baseline, though statistical significance was not reached.2 </span>
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>

              <!-- Desktop layout -->
              <div class="hidden md:flex gap-14">
                <div class="flex flex-col items-center flex-grow gap-2 pb-12 rounded-2xl sm:w-1/2 md:w-1/3">
                  <div class="px-24">
<img src="/themes/cholbam/images/icon-plasma.svg">
  
                  </div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="gap-4">
                      <p class="text-[26px] text-center text-teal">
                        <span class="text-[26px] font-semibold text-center">Increase plasma cholesterol</span><span class="text-[26px] text-center">â€&nbsp;</span>
                      </p>
                    </div>
                  </div>
                </div>
                <div class="flex flex-col items-center flex-grow gap-2 pb-12 rounded-2xl sm:w-1/2 md:w-1/3">
                  <div class="px-24">
<img src="/themes/cholbam/images/icon-enzymes.svg">
                  </div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="gap-4">
                      <p class="text-[26px] font-semibold text-center text-teal">
                        <span class="text-[26px] font-semibold text-center">Lower key liver </span><br><span class="text-[26px] font-semibold text-center">enzymes</span>
                      </p>
                      <div class="gap-4">
                        <p class="text-lg text-left text-text">
                          <span class="text-lg text-left">Alanine aminotransferase (ALT) or aspartate aminotransferase
                            (AST) values </span><span class="text-lg font-bold text-left">reduced</span><span class="text-lg text-left">
                            to less than 50 U/L, or baseline levels </span><span class="text-lg font-bold text-left">reduced</span><span class="text-lg text-left">
                            by 80%. </span><br><br><span class="text-lg text-left">Total bilirubin values </span><span class="text-lg font-bold text-left">reduced</span><span class="text-lg text-left">
                            to less than or equal to 1 mg/dL.</span>
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
                <div class="flex flex-col items-center flex-grow gap-2 rounded-2xl sm:w-2/2 md:w-1/3">
                  <div class="px-24">
<img src="/themes/cholbam/images/icon-growth.svg">
                  </div>
                  <div class="flex flex-col items-center gap-8">
                    <div class="gap-4">
                      <p class="text-[26px] font-semibold text-center text-teal">
                        Improve certain growth parameters
                      </p>
                      <div class="gap-4">
                        <p class="text-lg text-left text-text">
                          <span class="text-lg text-left">In a pivotal study, responders saw a </span><span class="text-lg font-bold text-left">10% increase in body weight or maintained weight above
                            the 50th
                            percentile</span><span class="text-lg text-left">.1*</span><br><br><span class="text-lg text-left">In a 2-month pilot study, 9 of 12 patients showed an </span><span class="text-lg font-bold text-left">increasing trend in weight gain</span><span class="text-lg text-left">
                            from baseline, though statistical significance was not reached.2 </span><br><br><span class="text-lg font-bold text-left">Statistically significant improvements in
                            height</span><span class="text-lg text-left">
                            have been reported.3</span>
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>

          <!-- Years of Clinical Data section -->
          <div class="opacity-90 gap-10 px-3 md:px-[150px] py-8 md:py-16">
            <div class="flex flex-col items-center flex-grow gap-10">
              <div class="gap-4">
                <p class="text-[32px] md:text-[40px] font-semibold text-center text-text">
                  <span class="font-semibold text-center">Years of Clinical Data and </span>
                  <span class="md:hidden"><br></span>
                  <span class="font-semibold text-center">Real-World Use</span>
                </p>
                <div class="flex justify-center gap-2.5">
                  <p class="w-full max-w-[704px] text-lg text-left text-text">
                    Backed by &gt;18 years of safety data, CHOLBAM has a well-characterized safety and
                    tolerability profile. There were 12 adverse reactions reported across 9 patients in
                    the clinical trials.1â€¡ In clinical trials, the most common adverse reaction (~2%)
                    reported was diarrhea.1
                  </p>
                </div>
              </div>

<!-- FDA approved banner -->
<div class="bg-[url('/themes/cholbam/images/bg-header-blue.svg')] bg-no-repeat bg-cover w-full bg-center py-10 px-5 md:py-12" style="background-size: 100% 100%;">
  <h2 class="text-white font-semibold text-center text-[26px] md:text-[32px]">
    CHOLBAM has been FDA approved and helping patients absorb what matters since 2015.
  </h2>
</div>

              <!-- Table section - only visible on desktop -->
              <div class="hidden md:block gap-8">
                <div class="gap-2.5 px-[104px]">
                  <div class="gap-8 px-8 rounded-[20px]">
                    <div>
                      <div class="gap-2.5">
                        <p class="text-[32px] text-left text-text">
                          <span class="text-[32px] font-semibold text-left">Most common adverse reactions in Trials 1
                            and 2</span><span class="text-[32px] text-left">1</span>
                        </p>
                      </div>
                    </div>
                    <!-- Table content remains unchanged for desktop -->
                    <div class="overflow-hidden rounded-xl bg-white shadow-[0px_0px_12px_0_rgba(160,94,166,0.12)]">
                      <!-- Table header and rows remain unchanged -->
                      <!-- ... -->
                    </div>
                  </div>
                </div>
              </div>

<div class="footnotes text-sm mt-8">
  <h2 class="font-semibold mb-4">Footnotes</h2>
  
  <p class="mb-2">
    No evaluable patients with SLOS were in the pivotal studies.<sup>1</sup> Patients had
    other bile acid synthesis disorders due to single enzyme defects.*
  </p>
  
  <p class="mb-2">
    In 11 of 12 patients with SLOS given CHOLBAM 10 mg/kg/day and cholesterol
    supplementation for 2 months, in an open-label, pilot study. Long-term studies
    are needed to determine durability of effect and possible clinical benefits.<sup>2</sup>
  </p>
  
  <p class="mb-4">
    Clinical safety experience with CHOLBAM consists of<sup>1</sup>:<br>
    Trial 1: a non-randomized, open-label, single-arm trial of 50 patients with
    bile acid synthesis disorders due to single enzyme defects (SEDs) and 29
    patients with peroxisomal disorders (PDs) including Zellweger spectrum
    disorders. Safety data are available over the 18 years of the trial<br>
    Trial 2: an extension trial of 12 new patients (10 SED and 2 PD) along with
    31 (21 SED and 10 PD) patients who rolled over from Trial 1<br>
    Safety data are available for 3 years and 11 months of treatment. Adverse
    events were not collected systematically in either of these trials. Most
    patients received an oral dose of 10 to 15 mg/kg/day of CHOLBAM.
  </p>
  
  <p>
    Adverse reactions that occurred in new patients.§
  </p>
</div>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>